Utah Medical Products UTMD Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's additional paid-in capital?
- Utah Medical Products (UTMD) reported additional paid-in capital of $0 in Q1 2026.
- What is the long-term trend for Utah Medical Products's additional paid-in capital?
- Over 5 years (2020 to 2025), Utah Medical Products's additional paid-in capital has grown at a -100.0% compound annual growth rate (CAGR), from $115K to $0.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.